Wen Qing Liang
Algemeen Directeur bij CF PharmTech, Inc
Profiel
Wen Qing Liang is currently the Chairman & General Manager at CF PharmTech, Inc since 2020.
Prior to this, he had worked at CF PharmTech, Inc since 2013.
Dr. Liang holds a doctorate degree from the University of Massachusetts, which he received in 1996.
Actieve functies van Wen Qing Liang
| Bedrijven | Functie | Begin |
|---|---|---|
CF PharmTech, Inc
 CF PharmTech, Inc Medical SpecialtiesHealth Technology CF PharmTech, Inc engages in the research, development, production and sale of respiratory diseases pharmaceutical products. It mainly involves in complex product & platform, innovative medicines, medical devices, & provide technical services. The company offers inhalers, asthma treatment products including Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray. CF PharmTech was founded by Li LI in 2007 and is headquartered in Suzhou, China. | Algemeen Directeur | 17-09-2020 |
Opleiding van Wen Qing Liang
| University of Massachusetts | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
CF PharmTech, Inc
CF PharmTech, Inc Medical SpecialtiesHealth Technology CF PharmTech, Inc engages in the research, development, production and sale of respiratory diseases pharmaceutical products. It mainly involves in complex product & platform, innovative medicines, medical devices, & provide technical services. The company offers inhalers, asthma treatment products including Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray. CF PharmTech was founded by Li LI in 2007 and is headquartered in Suzhou, China. | Health Technology |
